Frequently Asked Questions:
The COVID-19 pandemic has affected the North American on-site preventive care market in both positive and negative ways. While there is a higher demand for on-site testing, screening, and vaccination services due to a focus on employee health and safety, the decline in on-site workers due to remote work arrangements has affected the demand for these services. Additionally, disruptions in the supply chain for healthcare products and services have impacted the availability and cost of on-site preventative care services.
Increased awareness and attention on employee health and wellness, rising healthcare expenses, and a growing tendency towards preventive care and early disease diagnosis are the primary drivers for the growth of the North American on-site preventive care market.
The chronic disease management segment had a major market share in 2022.
The in-house management model segment had a major market share.